Blog Comments

Kinetica Online is pleased to provide direct links to commentaries from our senior editor Dr. Steven Pelech has posted on other blogs sites. Most of these comments appear on the GenomeWeb Daily Scan website, which in turn highlight interesting blogs that have been posted at numerous sites in the blogosphere since the beginning of 2010. A wide variety of topical subjects are covered ranging from the latest scientific breakthroughs, research trends, politics and career advice. The original blogs and Dr. Pelech’s comments are summarized here under the title of the original blog. Should viewers wish to add to these discussions, they should add their comments at the original blog sites.

The views expressed by Dr. Pelech do not necessarily reflect those of the other management and staff at Kinexus Bioinformatics Corporation. However, we wish to encourage healthy debate that might spur improvements in how biomedical research is supported and conducted.

Investment in China

Hao Xin in ScienceInsider wrote that Merck plans to spend about $1.5 billion on R&D in China over the next five years, starting with a staff of 260 in a Beijing facility to be expanded to ultimately 600. S. Pelech comments that Merck's increased investment in research in China will most likely be accompanied by further reductions in R&D spending in Europe and North America. The Chinese government's policy of restricting the export of clinical material out of China has made it necessary for pharmaceutical companies to undertake the evaluations of their clinical trials within that country. Read More...